Cell‐cell contact activation of fibroblasts increases the expression of matrix metalloproteinases

References

• Bizik J., Kankuri E., Ristimäki A., Taieb A., Vapaatalo H., Lubitz W., et al. Cell‐cell contacts trigger programmed necrosis and induce cyclooxygenase‐2 expression. Cell Death Differ 2004; 11: 183–95
   PubMed Web of Science ®Google Scholar
• Arends M. J., Wyllie A. H. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223–54
   PubMedGoogle Scholar
• Vu T. H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000; 14: 2123–33
   PubMed Web of Science ®Google Scholar
• Daniels J. T., Geerling G., Alexander R. A., Murphy G., Khaw P. T., Saarialho‐Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res 2003; 77: 653–64
   PubMed Web of Science ®Google Scholar
• Chang C., Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001; 11: S37–43
   PubMed Web of Science ®Google Scholar
• McCawley L. J., Matrisian L. M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001; 13: 534–40
   PubMed Web of Science ®Google Scholar
• Owen C. A., Hu Z., Lopez‐Otin C., Shapiro S. D. Membrane‐bound matrix metalloproteinase‐8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase‐resistant collagenase and serpinase. J Immunol 2004; 172: 7791–803
   PubMed Web of Science ®Google Scholar
• Gueders M. M., Balbin M., Rocks N., Foidart J. M., Gosset P., Louis R., et al. Matrix metalloproteinase‐8 deficiency promotes granulocytic allergen‐induced airway inflammation. J Immunol 2005; 175: 2589–97
   PubMed Web of Science ®Google Scholar
• Nagase H., Woessner J. F., Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491–4
   PubMed Web of Science ®Google Scholar
• Sternlicht M. D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463–516
   PubMed Web of Science ®Google Scholar
• Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161–74
   PubMed Web of Science ®Google Scholar
• Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827–39
   PubMed Web of Science ®Google Scholar
• Baker A. H., Edwards D. R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002; 115: 3719–27
   PubMed Web of Science ®Google Scholar
• Will H., Atkinson S. J., Butler G. S., Smith B., Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP‐2 and TIMP‐3. J Biol Chem 1996; 271: 17119–23
   PubMed Web of Science ®Google Scholar
• Smith R. S., Smith T. J., Blieden T. M., Phipps R. P. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997; 151: 317–22
   PubMed Web of Science ®Google Scholar
• Silzle T., Randolph G. J., Kreutz M., Kunz‐Schughart L. A. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 2004; 108: 173–80
   PubMed Web of Science ®Google Scholar
• Gabbiani G., Chaponnier C., Huttner I. Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing. J Cell Biol 1978; 76: 561–8
   PubMed Web of Science ®Google Scholar
• Lindy O., Konttinen Y. T., Sorsa T., Ding Y., Santavirta S., Ceponia A., et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997; 40: 1391–9
   PubMed Web of Science ®Google Scholar
• Prikk K., Maisi P., Pirilä E., Reintam M. A., Salo T., Sorsa T., et al. Airway obstruction correlates with collagenase‐2 (MMP‐8) expression and activation in bronchial asthma. Lab Invest 2002; 82: 1535–45
   PubMedGoogle Scholar
• Stephens R. W., Leung K. ‐. C., Pöllänen J., Salonen E. ‐. M., Vaheri A. Microplate immunoassay for plasminogen activators and their specific inhibitors. J Immunol Methods 1987; 105: 245–51
   PubMedGoogle Scholar
• Saksela O. Radial caseinolysis in agarose: A simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Anal Biochem 1981; 111: 276–82
   PubMed Web of Science ®Google Scholar
• Kankuri E., Cholujova D., Comajova M., Vaheri A., Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res 2005; 65: 9914–22
   PubMed Web of Science ®Google Scholar
• Knäuper V., Murphy G., Tschesche H. Activation of human neutrophil procollagenase by stromelysin 2. Eur J Biochem 1996; 235: 187–91
   PubMedGoogle Scholar
• Seiki M. Membrane‐type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 2003; 194: 1–11
   PubMed Web of Science ®Google Scholar
• Pillinger M. H., Rosenthal P. B., Tolani S. N., Apsel P., Dinsell V., Greenberg J., et al. Cyclooxygenase‐2‐derived E prostaglandins down‐regulate matrix metalloproteinase‐1 expression in fibroblast‐like synoviocytes via inhibition of extracellular signal‐regulated kinase activation. J Immunol 2003; 171: 6080–9
   PubMed Web of Science ®Google Scholar
• Rechardt O., Elomaa O., Vaalamo M., Paakkonen K., Jahkola T., Hook‐Nikanne J., et al. Stromelysin‐2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 2000; 115: 778–87
   Google Scholar
• Holopainen J. M., Moilanen J. A., Sorsa T., Kivelä‐Rajamäki M., Tervahartiala T., Vesaluoma M. H., et al. Activation of matrix metalloproteinase‐8 by membrane type 1‐MMP and their expression in human tears after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2003; 44: 2550–6
   PubMed Web of Science ®Google Scholar
• Gingras D., Bousquet‐Gagnon N., Langlois S., Lachambre M. P., Annabi B., Beliveau R. Activation of the extracellular signal‐regulated protein kinase (ERK) cascade by membrane‐type‐1 matrix metalloproteinase (MT1‐MMP). FEBS Lett 2001; 507: 231–6
   PubMed Web of Science ®Google Scholar
• Li H., Bauzon D. E., Xu X., Tschesche H., Cao J., Sang Q. A. Immunological characterization of cell‐surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol Carcinogen 1998; 56: 84–94
   Google Scholar
• Tervahartiala T., Pirilä E., Ceponis A., Maisi P., Salo T., Tuter G., et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP‐2, ‐8, ‐13, and ‐14) and matrilysin (MMP‐7) in adult and localized periodontitis. J Dent Res 2000; 79: 1969–77
   PubMed Web of Science ®Google Scholar
• Maisi P., Prikk K., Sepper R., Pirilä E., Salo T., Hietanen J., et al. Soluble membrane‐type 1 matrix metalloproteinase (MT1‐MMP) and gelatinase A (MMP‐2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 2002; 110: 771–82
   PubMed Web of Science ®Google Scholar
• Lindsey M. L. MMP induction and inhibition in myocardial infarction. Heart Fail Rev 2004; 9: 7–19
   PubMed Web of Science ®Google Scholar
• Palolahti M., Lauharanta J., Stephens R. W., Kuusela P., Vaheri A. Proteolytic activity in leg ulcer exudates. Exp Dermatol 1993; 2: 29–37
   PubMedGoogle Scholar
• Shah P. K. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 1998; 3: 199–206
   PubMedGoogle Scholar
• Sirén V., Kauhanen P., Carpén O., Luther M., Lepäntalo M., Vaheri A., et al. Urokinase, tissue‐type plasminogen activator and plasminogen activator inhibitor‐1 expression in severely stenosed and occluded vein grafts with thrombosis. Blood Coagul Fibrin 2003; 14: 369–77
   Google Scholar
• Pagano M., Benmaamar R. When protein destruction runs amok, malignancy is on the loose. Cancer Cell 2003; 4: 251–6
   PubMed Web of Science ®Google Scholar